Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
WRAL Weather Alert Day: Memorial Day brings level 2 risk of severe storms, with threat of damaging winds, isolated tornadoes and large hail.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Therapeutics Inc
(NQ:
APLT
)
4.080
+0.040 (+0.99%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Applied Therapeutics Inc
< Previous
1
2
Next >
Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe
January 04, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Reports Third Quarter 2022 Financial Results
November 09, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022
October 31, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy
October 25, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded Format
October 06, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference
July 28, 2022
From
Applied Therapeutics
Via
GlobeNewswire
NASDAQ:APLT Investor Alert: Investigation over Potential Wrongdoing at Applied Therapeutics, Inc.
April 11, 2022
San Diego, CA -- (SBWIRE) -- 04/11/2022 -- Certain directors of Applied Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
NASDAQ:APLT Investor Notice: Investigation over Possible Securities Laws Violations by Applied Therapeutics, Inc.
January 27, 2022
San Diego, CA -- (SBWIRE) -- 01/27/2022 -- Applied Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
APPLIED THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Applied Therapeutics, Inc. on Behalf of Applied Therapeutics Stockholders and Encourages Investors to Contact the Firm
January 18, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Applied Therapeutics, Inc. (APLT) on Behalf of Shareholders
January 10, 2022
From
Robbins LLP
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Applied Therapeutics, Inc. (APLT) Investigation
January 06, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.